🔎 Trials Near Me

Home › Colon Cancer › Washington › Seattle

Pag-aaral pangklinika para sa Colon Cancer sa Seattle, WA

Isang pag-aaral para sa Colon Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Seattle. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
  • Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale · 17 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07283939

Family Communications After Genetic Testing

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
  • at 1 pa
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07143487

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Nagre-recruitPhase 3
  • Fred Hutchinson Cancer Center ( Site 0076), Seattle
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06997497

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Nagre-recruitPhase 3
  • Swedish Cancer Institute, Seattle
  • Fred Hutchinson Cancer Center, Seattle
  • Swedish Medical Center, Seattle
  • at 1 pa
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07222800

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Nagre-recruit
  • Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale · 17 mi ang layo
Edad 45 hanggang 70 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05080673

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Nagre-recruitPhase 2/3
  • Virginia Mason Medical Center, Seattle
  • Fred Hutchinson Cancer Center, Seattle
  • Swedish Medical Center-First Hill, Seattle
  • at 3 pa
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05174169

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Nagre-recruitPhase 1
  • Xencor Investigative Site, Seattle
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT05433142

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Nagre-recruitPhase 1/2
  • Fred Hutchinson Cancer Center, Seattle
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT06051695

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Nagre-recruitPhase 1/2
  • Virginia Mason Medical Center, Seattle
Edad 18 pataas · Lahat ng kasarian · Na-update May 15, 2026 · NCT05379985

Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

Nagre-recruitObservasyonal na pag-aaral
  • University of Washington, Seattle
Edad 18 pataas · Lahat ng kasarian · Na-update May 11, 2026 · NCT00843375

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral
  • Massive Bio SYNERGY-AI site, Seattle
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Nagre-recruitPhase 1/2
  • Fred Hutch Cancer Center, Seattle
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2025 · NCT06682793

Pag-aaral para sa Colon Cancer sa ibang lungsod

Iba pang pag-aaral sa Seattle

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.